Virax Biolabs (VRAX) - 2026 Q2 - Quarterly Report

Exhibit 99.1 Unaudited Condensed Consolidated Interim Financial Statements as of September 30, 2025 | Page | | | --- | --- | | Condensed Consolidated Statements of Financial Position as of September 30, 2025 and March 31, 2025 | F-2 | | (Unaudited) | | | Condensed Consolidated Statements of Loss and Other Comprehensive Loss for the Six Months Ended September | F-3 | | 30, 2025 and 2024 (Unaudited) | | | Condensed Consolidated Statements of Changes in Equity for the Six Months Ended September 30, 2025 and 20 ...